Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin
Appendectomy
Locations
25
United States
Olive View-UCLA Medical Center
Sylmar, California, United States
Harbor-UCLA Medical Center
Torrance, California, United States
University of Colorado Denver
Aurora, Colorado, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Maine Medical Center
Portland, Maine, United States
Start Date
May 1, 2016
Primary Completion Date
March 5, 2020
Completion Date
September 1, 2021
Last Updated
May 6, 2023
NCT07008092
NCT06083064
NCT04039750
NCT06834958
NCT07479849
NCT06808087
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions